HDFC Mutual Fund Expands Stake in Global Health with ₹130 Crore Deal

HDFC Mutual Fund has significantly increased its position in Global Health, the parent company of the renowned Medanta hospital chain, through a substantial open market transaction. This latest acquisition underscores the growing institutional confidence in the healthcare sector's premium player.

Details of the Block Deal

In a significant move on Thursday, HDFC Mutual Fund acquired an additional 10 lakh shares of Global Health from the company's co-founder, Sunil Sachdeva. The transaction, conducted through open market trades, was valued at approximately ₹130 crore. The shares were purchased at an average price of ₹1,300 per share, representing a 0.37 per cent stake in the company.

This move follows a similar high-value transaction conducted just last month, where HDFC Mutual Fund purchased another 10 lakh shares from Sachdeva for over ₹122 crore. The repeated interest from one of India's largest asset management companies suggests a bullish long-term outlook on Medanta's business model.

Impact on Promoter Holding

The sale of shares by Sunil Sachdeva marks a notable shift in the promoter's equity structure. As of the end of the March quarter, Sachdeva held a significant stake of 10.79 per cent, comprising 2.90 crore equity shares. By offloading these shares to institutional investors like HDFC MF, the promoter's direct holding undergoes a gradual transition toward more institutional ownership.

Despite the large-scale block deal, the market reaction was relatively stable, with Global Health shares slipping slightly by 0.41 per cent to close at ₹1,311.35 apiece on the BSE.

Robust Financial Performance of Global Health

The institutional appetite for Global Health is likely driven by the company's impressive financial trajectory. For the fourth quarter ended March 31, 2026, the company reported a stellar 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore compared to ₹101.4 crore in the same period of the previous fiscal year.

The company's top-line growth has been equally aggressive. Revenue from operations for the quarter stood at ₹1,159 crore, a sharp increase from the ₹931.3 crore reported in the year-ago period. This combination of rapid revenue scaling and significant profit expansion highlights the operational efficiency and market demand for the Medanta healthcare brand.

Key Takeaways

  • Strategic Accumulation: HDFC Mutual Fund has bought 10 lakh shares of Global Health at ₹1,300 per share, totaling a ₹130 crore investment.
  • Promoter Exit: The shares were acquired from co-founder Sunil Sachdeva, marking a repeat of a similar large-scale transaction conducted last month.
  • Strong Fundamentals: The deal comes amidst a period of high growth for Global Health, which saw a nearly 40% jump in quarterly PAT to ₹141.7 crore.